Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Silicosis - Harnessing New Ideas to Conquer the Re-emergence of an Ancient Lung Disease: The SHIELD Whole Lung Lavage Study

NCT05402176 is registered in ClinicalTrials.gov with The University of Queensland as lead sponsor.

NCT NCT05402176
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT05402176 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Silicosis - Harnessing New Ideas to Conquer the Re-emergence of an Ancient Lung Disease: The SHIELD Whole Lung Lavage Study
Lead sponsor
The University of Queensland
Phase
Observational
Overall status
Unknown status
Start date
June 30, 2022
Completion date
December 31, 2024
Enrollment
30 (estimated)
Sites
4

Conditions

As the registry lists them; a condition with its own page is linked.

silicosis